Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Zyla Life Sciences similar filings
- 6 Aug 14 Egalet Announces Topline Results from Bioequivalence Studies of Abuse-Deterrent Morphine, Egalet-001
- 28 Jul 14 Egalet Appoints Jeffrey M. Dayno, M.D. as Chief Medical Officer
- 15 Jul 14 Egalet Reports Positive Top-Line Results from Category 1 Abuse Deterrence Studies Demonstrating Egalet-001 Resists Physical and Chemical Manipulation
- 10 Jun 14 Submission of Matters to a Vote of Security Holders
- 13 May 14 Egalet Reports First Quarter 2014 Financial Results and Provides Business Update
- 31 Mar 14 Egalet Reports Positive Outcome of First Phase of Category 1 Abuse Deterrence Studies for Egalet-001
- 26 Mar 14 Egalet Reports Full Year 2013 Financial Results and Provides Business Update
Filing view
External links